Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.
Research output: Contribution to conference › Paper
Standard Standard
Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease. / Hughes, D.; Hughes, D.A.; Bodger, K. et al.
2008. Paper presented at Clinical Pharmacology Colloquium, Bangor University, Wales, UK.
2008. Paper presented at Clinical Pharmacology Colloquium, Bangor University, Wales, UK.
Research output: Contribution to conference › Paper
HarvardHarvard
Hughes, D, Hughes, DA, Bodger, K & Kikuchi, T 2008, 'Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.', Paper presented at Clinical Pharmacology Colloquium, Bangor University, Wales, UK, 3/01/01.
APA
Hughes, D., Hughes, D. A., Bodger, K., & Kikuchi, T. (2008). Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.. Paper presented at Clinical Pharmacology Colloquium, Bangor University, Wales, UK.
CBE
Hughes D, Hughes DA, Bodger K, Kikuchi T. 2008. Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease. Paper presented at Clinical Pharmacology Colloquium, Bangor University, Wales, UK.
MLA
Hughes, D. et al. Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.. Clinical Pharmacology Colloquium, Bangor University, Wales, UK, 03 Jan 0001, Paper, 2008.
VancouverVancouver
Hughes D, Hughes DA, Bodger K, Kikuchi T. Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.. 2008. Paper presented at Clinical Pharmacology Colloquium, Bangor University, Wales, UK.
Author
RIS
TY - CONF
T1 - Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.
AU - Hughes, D.
AU - Hughes, D.A.
AU - Bodger, K.
AU - Kikuchi, T.
PY - 2008/4/1
Y1 - 2008/4/1
M3 - Paper
T2 - Clinical Pharmacology Colloquium, Bangor University, Wales, UK
Y2 - 3 January 0001
ER -